Public Calendar: August 4-10, 2019
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs
No Significant Event
Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name: Lowell J. Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 08/06/2019
Location: Silver Spring, MD
Subject: Traceability
FDA Participant/Group: KARI BARRETT; LARRY MORRIS; CAITLIN BOON;
Non FDA Participant/Group: Betsy Booren, Michael Gruber (Grocery Manufacturers Association);
Event Date: 08/08/2019
Location: College Park, MD
Subject: Lab Accreditation
FDA Participant/Group: TIMOTHY MCGRATH; LARRY MORRIS; ERIK METTLER; JAN CARLSON; CHARLOTTE CHRISTIN; PAUL NORRIS;
Non FDA Participant/Group: Several members from the American Council of Independent Laboratories (ACIL)
Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 08/06/2019
Location: Silver Spring, MD
Subject: Infection Prevention with Medical Devices
FDA Participant/Group: WILLIAM MAISEL; ELIZABETH CLAVERIE; SUZANNE SCHWARTZ; SHANIL HAUGEN; MICHAEL RYAN;
Non FDA Participant/Group: Brian Motter, Jason Ashraf, Jordan Cooper, Ken Yoshimasu (Olympus Corporation); Nacho Abia (Olympus Corporation of the Americas);
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 08/08/2019
Location: College Park, MD
Subject: Labeling of Plant-Based Dairy Alternative Products
FDA Participant/Group: ELIZABETH BRICZINSKI; CONRAD CHOINIERE; CAROLYN JASPERSE; LESLIE KUX; EMILY ROSE CAREY;
Non FDA Participant/Group: Clay Delefsen, Donnelly McDowell, Jim Mulhern, Sarah Roller, Tom Balmer (National Milk Producers Federation);
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
Event Date: 08/08/2019
Location: Little Rock, AR
Subject: Arkansas Research Alliance Board Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event